Istaroxime, LActose
04-CL-2201
Phase 2 small_molecule active
Quick answer
Istaroxime, LActose for Cardiogenic Shock is a Phase 2 program (small_molecule) at WINDTREE THERAPEUTICS INC /DE/ with 1 ClinicalTrials.gov record(s).
Program details
- Company
- WINDTREE THERAPEUTICS INC /DE/
- Indication
- Cardiogenic Shock
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active